Related Experiment Video
Updated: Aug 11, 2026

Using a 1064-nm Picosecond Neodymium-Doped Yttrium Aluminum Garnet Laser for Periorbital Hyperpigmentation
Published on: May 23, 2025
Complications following pulsed dye laser treatment of superficial hemangiomas
Patricia M Witman1, Annette M Wagner, Kathrin Scherer
1Department of Dermatology, Mayo Clinic and Foundation, Rochester, Minnesota 55905, USA. witman.patricia@mayo.edu
Insights
Pulsed dye laser (PDL) treatment for infantile hemangiomas can lead to serious complications. Early treatment of superficial facial hemangiomas with PDL may result in ulceration, scarring, and hemorrhage.
Area of Science:
- Dermatology
- Pediatric Medicine
- Laser Therapy
Background:
- Pulsed dye laser (PDL) is a common treatment for infantile hemangiomas.
- Previous reports indicate PDL is generally safe and effective for superficial infantile hemangiomas.
Observation:
- This study reviewed 12 infants with hemangiomas experiencing adverse outcomes after PDL treatment.
- All patients were treated at a young age (5 days to 4 months) for superficial facial hemangiomas.
Findings:
- Eleven patients received PDL at 585 nm (4.7-7 J/cm²) without dynamic cooling; one received 595 nm (7-12 J/cm²) with dynamic cooling.
- Eight patients developed severe ulceration, pain, scarring, and one experienced life-threatening hemorrhage.
- Four patients had permanent atrophic scarring without ulceration.
Implications:
- PDL treatment for superficial infantile hemangiomas carries a risk of significant complications.
- Careful patient selection and treatment parameters are crucial to minimize adverse effects like scarring and ulceration.
Background And Objective:
Pulsed dye laser (PDL) has been reported to be safe and effective in the management of superficial hemangiomas of infancy. We report 12 patients with hemangiomas with complications following PDL.
Study Design/Materials And Methods:
Records of patients with hemangiomas and a known adverse outcome following PDL were reviewed.
Results:
All were treated early (age range: 5 days to 4 months), and all hemangiomas were facial with a superficial component. Eleven were treated with a 585 nm wavelength, fluence range of 4.7-7 J/cm(2), without dynamic cooling. One patient received 7-12 J/cm(2) utilizing a 595 nm wavelength with dynamic cooling. In eight cases, treatment led to severe ulceration with subsequent pain, scarring, and in one instance, life-threatening hemorrhage. In four, permanent atrophic scarring was noted without ulceration.
Conclusions:
PDL treatment of superficial hemangiomas may rarely lead to significant complications including atrophic scarring and severe ulceration.
Related Concept Videos
Healing II: Complications
Varicose Veins II: Diagnostic Studies and Interprofessional Care
Hemodialysis II: Procedure and Complications
